177 related articles for article (PubMed ID: 26311289)
1. Adherence to Anticoagulant Therapy in Pediatric Patients Hospitalized With Pulmonary Embolism or Deep Vein Thrombosis: A Retrospective Cohort Study.
Singh RR; Gupte-Singh KR; Wilson JP; Moffett BS
Clin Appl Thromb Hemost; 2016 Apr; 22(3):260-4. PubMed ID: 26311289
[TBL] [Abstract][Full Text] [Related]
2. Treatment of venous thromboembolism: adherence to guidelines and impact of physician knowledge, attitudes, and beliefs.
Caprini JA; Tapson VF; Hyers TM; Waldo AL; Wittkowsky AK; Friedman R; Colgan KJ; Shillington AC;
J Vasc Surg; 2005 Oct; 42(4):726-33. PubMed ID: 16242561
[TBL] [Abstract][Full Text] [Related]
3. Warfarin Discontinuation in Patients With Unprovoked Venous Thromboembolism: A Large US Insurance Database Analysis.
Xie L; Liu X; Phatak H; Mardekian J; Tan W; Baser O; Ramacciotti E
Am J Ther; 2016; 23(6):e1744-e1753. PubMed ID: 26214203
[TBL] [Abstract][Full Text] [Related]
4. Length of stay and economic consequences with rivaroxaban vs enoxaparin/vitamin K antagonist in patients with DVT and PE: findings from the North American EINSTEIN clinical trial program.
Bookhart BK; Haskell L; Bamber L; Wang M; Schein J; Mody SH
J Med Econ; 2014 Oct; 17(10):691-5. PubMed ID: 25065536
[TBL] [Abstract][Full Text] [Related]
5. Anticoagulant treatment of deep vein thrombosis and pulmonary embolism.
Tran H; McRae S; Ginsberg J
Cardiol Clin; 2008 May; 26(2):235-50, vi-vii. PubMed ID: 18406997
[TBL] [Abstract][Full Text] [Related]
6. Home treatment of deep venous thrombosis in the era of new oral anticoagulants.
Stein PD; Matta F; Hughes PG; Ghiardi M; Marsh JH; Khwarg J; Brandon MS; Fowkes HA; Kazan V; Wiepking M; Keyes DC; Kakish EJ; Hughes MJ
Clin Appl Thromb Hemost; 2015 Nov; 21(8):729-32. PubMed ID: 26239315
[TBL] [Abstract][Full Text] [Related]
7. Long-term efficacy and safety of once-daily enoxaparin plus warfarin for the outpatient ambulatory treatment of lower-limb deep vein thrombosis in the TROMBOTEK trial.
Kurtoglu M; Koksoy C; Hasan E; Akcalı Y; Karabay O; Filizcan U;
J Vasc Surg; 2010 Nov; 52(5):1262-70. PubMed ID: 20732787
[TBL] [Abstract][Full Text] [Related]
8. [Improving recanalization of deep veins and the "outcomes" of venous thromboembolic complications in prolonged therapy with enoxaparin].
Vorob'eva NM; Panchenko EP; Dobrovol'skiĭ AB; Titaeva EV; Ermolina OV; Balakhonova TV; Kirienko AI
Angiol Sosud Khir; 2010; 17(1):87-94. PubMed ID: 21780625
[TBL] [Abstract][Full Text] [Related]
9. [Prolongation of enoxaparin therapy to one month promotes recanalization of the occlusively thrombosed deep veins].
Vorob'eva NM; Panchenko EP; Ermolina OV; Balakhonova TV; Dobrovol'skiĭ AB; Titaeva EV; Khasanova ZB; Postnov AIu; Kirienko AI
Ter Arkh; 2011; 83(8):33-7. PubMed ID: 21961329
[TBL] [Abstract][Full Text] [Related]
10. Daily hospitalization costs in patients with deep vein thrombosis or pulmonary embolism treated with anticoagulant therapy.
Dasta JF; Pilon D; Mody SH; Lopatto J; Laliberté F; Germain G; Bookhart BK; Lefebvre P; Nutescu EA
Thromb Res; 2015 Feb; 135(2):303-10. PubMed ID: 25555319
[TBL] [Abstract][Full Text] [Related]
11. Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trial.
Fiessinger JN; Huisman MV; Davidson BL; Bounameaux H; Francis CW; Eriksson H; Lundström T; Berkowitz SD; Nyström P; Thorsén M; Ginsberg JS;
JAMA; 2005 Feb; 293(6):681-9. PubMed ID: 15701909
[TBL] [Abstract][Full Text] [Related]
12. Shorter Hospital Stays and Lower Costs for Rivaroxaban Compared With Warfarin for Venous Thrombosis Admissions.
Margolis JM; Deitelzweig S; Kline J; Tran O; Smith DM; Bookhart B; Crivera C; Schein J
J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27792638
[TBL] [Abstract][Full Text] [Related]
13. Direct oral anticoagulant prescription trends, switching patterns, and adherence in Texas Medicaid.
Wong SL; Marshall LZ; Lawson KA
Am J Manag Care; 2018 Jul; 24(8 Spec No.):SP309-SP314. PubMed ID: 30020743
[TBL] [Abstract][Full Text] [Related]
14. [Clinical analysis of 20 pregnant women with venous thromboembolic disease].
Sun P; Dong DN
Zhonghua Fu Chan Ke Za Zhi; 2011 Dec; 46(12):911-6. PubMed ID: 22333281
[TBL] [Abstract][Full Text] [Related]
15. Reduction in the length of stay with rivaroxaban as a single-drug regimen for the treatment of deep vein thrombosis and pulmonary embolism.
van Bellen B; Bamber L; Correa de Carvalho F; Prins M; Wang M; Lensing AW
Curr Med Res Opin; 2014 May; 30(5):829-37. PubMed ID: 24432872
[TBL] [Abstract][Full Text] [Related]
16. [Warfarin or enoxaparin: the choice for the patient with venous thrombosis in the first month of treatment].
Vorob'eva NM; Panchenko EP; Kirienko AI; Dobrovol'skiĭ AB; Titaeva EV; Ermolina OV; Balakhonova TV; Andriiashkin VV; Leont'ev SG
Ter Arkh; 2009; 81(9):57-61. PubMed ID: 19827655
[TBL] [Abstract][Full Text] [Related]
17. A cost-analysis model for anticoagulant treatment in the hospital setting.
Mody SH; Huynh L; Zhuo DY; Tran KN; Lefebvre P; Bookhart B
J Med Econ; 2014 Jul; 17(7):492-8. PubMed ID: 24773068
[TBL] [Abstract][Full Text] [Related]
18. Rate and duration of hospitalization for deep vein thrombosis and pulmonary embolism in real-world clinical practice.
Dentali F; Di Micco G; Giorgi Pierfranceschi M; Gussoni G; Barillari G; Amitrano M; Fontanella A; Lodigiani C; Guida A; Visonà A; Monreal M; Di Micco P
Ann Med; 2015; 47(7):546-54. PubMed ID: 26422329
[TBL] [Abstract][Full Text] [Related]
19. Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement.
Bergqvist D; Benoni G; Björgell O; Fredin H; Hedlundh U; Nicolas S; Nilsson P; Nylander G
N Engl J Med; 1996 Sep; 335(10):696-700. PubMed ID: 8703168
[TBL] [Abstract][Full Text] [Related]
20. Managing pulmonary embolism from presentation to extended treatment.
Cohen AT; Dobromirski M; Gurwith MM
Thromb Res; 2014 Feb; 133(2):139-48. PubMed ID: 24182642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
